Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

InspireMD Inc.

NSPRNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Nov 17, 2026Accepted Nov 17, 2026, 4:05 PM ESTFiling CIK 1433607Accession 0001493152-26-052825
Share

Structured filing — 4

ownership.xml

Open full document ↗

Filing details

Report period
2026-11-13
Issuer
InspireMD, Inc.
Issuer CIK
0001433607
Trading symbol
NSPR

Reporting owner 1

Name
BERMAN MICHAEL
Reporting owner CIK
0001186801
Relationship
Director
Address
C/O INSPIREMD, INC., 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI, FL, 33126

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-11-13P · Form 476,923[F1]A0.65429,509D
Table key
P · Form 4
Purchase on the market or privately
A
Acquired
D
Direct

Non-derivative holdings

Non-derivative holdings · 1 reported row
SecurityAmount ownedOwnershipNature of ownership
Common Stock244,994ISee Footnote[F2]
Table key
I
Indirect

Derivative transactions

Derivative transactions · 1 reported row
SecurityConversion / exercise price (USD)Transaction dateCodeAmountA / DPrice (USD)ExercisableExpiresUnderlying securityUnderlying sharesOwned afterOwnership
Series L Common Stock Warrant[F3]0.652026-11-13P · Form 457,692A0.002026-11-162027-11-16Common Stock57,69257,692D
Table key
P · Form 4
Purchase on the market or privately
A
Acquired
D
Direct

Footnotes

F1
Represents shares of common stock purchased by the Reporting Person in the Issuer's underwritten public offering at a combined public offering price of $0.65 per share of common stock and accompanying Series L common stock warrants.↩ 1
F2
These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.↩ 1
F3
The Series L common stock warrants are immediately exercisable at an exercise price of $0.65 per share and expire on November 16, 2027.↩ 1

Signature 1

Signed
/s/ Michael Lawless, Attorney-in-Fact for Michael Berman
Date
2026-11-17

Company context

InspireMD seeks to utilize its proprietary MicroNet ™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.

Current securities

Historical securities (4)

Recent company filings

  1. Other EventsNov 20, 2026
  2. 4 filingNov 17, 2026
  3. 10-Q filingNov 16, 2026
  4. Entry into a Material Definitive Agreement · Other EventsNov 16, 2026
  5. 424B5 filingNov 16, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.